Vivaldo Moura-Neto
Overview
Explore the profile of Vivaldo Moura-Neto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
1587
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pilotto Heming C, de Souza Barbosa I, Lyra Miranda R, Nogueira Ugarte O, Santorio de Sao Jose V, Moura Neto V, et al.
Am J Pathol
. 2025 Jan;
PMID: 39788485
Drug resistance is a major challenge in cancer therapy, and the expression of efflux pumps such as P-glycoprotein (P-gp, ABCB1) often correlates with poor prognosis in various tumors, including glioblastoma...
2.
Aran V, Lyra Miranda R, Heringer M, da Fonseca A, Andreiuolo F, Chimelli L, et al.
Front Neurol
. 2024 Jan;
14:1321895.
PMID: 38259646
Introduction: Liquid biopsy is a non-invasive method used to detect cancer and monitor treatment responses by analyzing blood or other bodily fluids for cancer biomarkers. Meningiomas are the most common...
3.
Guterres A, Filho P, Moura-Neto V
Vaccines (Basel)
. 2024 Jan;
12(1).
PMID: 38250874
The use of mRNA-based immunotherapies that leverage the genomes of oncolytic viruses holds significant promise in addressing glioblastoma (GBM), an exceptionally aggressive neurological tumor. We explore the significance of mRNA-based...
4.
Vieira B, Santorio de Sao Jose V, Niemeyer Filho P, Moura-Neto V
Int Immunopharmacol
. 2023 Aug;
123:110729.
PMID: 37536182
Background: Glioblastoma is the most common and lethal primary brain tumor in adults. Despite the available cancer treatments, the recurrence of the tumor is high, and the survival rate is...
5.
Garcez P, Guasti A, Ventura N, Higa L, Andreiuolo F, de Freitas G, et al.
Front Med (Lausanne)
. 2023 Jun;
10:1192070.
PMID: 37324152
Glioblastoma is the most frequent and aggressive primary brain cancer. In preclinical studies, Zika virus, a flavivirus that triggers the death of glioblastoma stem-like cells. However, the flavivirus oncolytic activity...
6.
Capra D, DosSantos M, Sanz C, Filha L, Nunes P, Heringer M, et al.
Front Microbiol
. 2023 May;
14:1162554.
PMID: 37125179
The inner ear, the organ of equilibrium and hearing, has an extraordinarily complex and intricate arrangement. It contains highly specialized structures meticulously tailored to permit auditory processing. However, hearing also...
7.
Pilotto Heming C, Niemeyer Filho P, Moura-Neto V, Aran V
Cancer Treat Res Commun
. 2023 Apr;
35:100709.
PMID: 37088042
Brain tumors are considered one of the deadliest types of cancer, being challenging to treat, especially due to the blood-brain barrier, which has been linked to treatment resistance. The genomic...
8.
Quincozes-Santos A, Bobermin L, Costa N, Thomaz N, de Souza Almeida R, Beys-da-Silva W, et al.
Glia
. 2023 Mar;
71(8):1791-1803.
PMID: 36866453
Zika virus (ZIKV) is a strongly neurotropic flavivirus whose infection has been associated with microcephaly in neonates. However, clinical and experimental evidence indicate that ZIKV also affects the adult nervous...
9.
Pilotto Heming C, Muriithi W, Wanjiku Macharia L, Niemeyer Filho P, Moura-Neto V, Aran V
Heliyon
. 2022 Nov;
8(10):e11171.
PMID: 36325145
Acquired resistance during cancer treatment is unfortunately a frequent event. There are several reasons for this, including the ability of the ATP-binding cassette transporters (ABC transporters), which are integral membrane...
10.
Loureiro A, Moura-Neto L, Martins C, Silva P, Lopes M, Leitao R, et al.
Front Immunol
. 2022 Sep;
13:956340.
PMID: 36072579
( produces toxins A (TcdA) and B (TcdB), both associated with intestinal damage and diarrhea. Pannexin-1 (Panx1) channels allows the passage of messenger molecules, such as adenosine triphosphate (ATP), which...